Ultragenyx Pharmaceutical Inc (RARE)
42.60
+1.48
(+3.60%)
USD |
NASDAQ |
May 16, 16:00
42.60
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Shares Outstanding: 83.13M for April 26, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 26, 2024 | 83.13M |
April 23, 2024 | 83.13M |
April 12, 2024 | 83.10M |
March 31, 2024 | 83.09M |
February 15, 2024 | 82.34M |
December 31, 2023 | 82.32M |
October 30, 2023 | 82.11M |
October 23, 2023 | 81.32M |
September 30, 2023 | 72.17M |
July 31, 2023 | 71.49M |
June 30, 2023 | 71.47M |
May 01, 2023 | 70.81M |
April 17, 2023 | 70.68M |
April 10, 2023 | 70.67M |
March 31, 2023 | 70.66M |
February 13, 2023 | 70.22M |
December 31, 2022 | 70.20M |
October 28, 2022 | 70.11M |
September 30, 2022 | 70.08M |
July 25, 2022 | 70.04M |
June 30, 2022 | 70.01M |
May 02, 2022 | 69.93M |
April 26, 2022 | 69.87M |
April 18, 2022 | 69.83M |
March 31, 2022 | 69.80M |
Date | Value |
---|---|
February 10, 2022 | 69.38M |
December 31, 2021 | 69.34M |
October 28, 2021 | 68.16M |
September 30, 2021 | 67.96M |
July 28, 2021 | 67.84M |
June 30, 2021 | 67.76M |
April 30, 2021 | 67.48M |
April 26, 2021 | 67.47M |
April 20, 2021 | 67.46M |
March 31, 2021 | 67.44M |
February 08, 2021 | 66.95M |
December 31, 2020 | 66.82M |
November 02, 2020 | 66.16M |
October 22, 2020 | 61.04M |
September 30, 2020 | 60.82M |
July 27, 2020 | 60.59M |
June 30, 2020 | 60.41M |
May 01, 2020 | 59.75M |
April 27, 2020 | 59.65M |
April 20, 2020 | 59.58M |
March 31, 2020 | 59.49M |
February 10, 2020 | 57.89M |
December 31, 2019 | 57.84M |
October 31, 2019 | 57.77M |
September 30, 2019 | 57.75M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
57.67M
Minimum
Jun 30 2019
83.13M
Maximum
Apr 23 2024
68.59M
Average
69.36M
Median
Shares Outstanding Benchmarks
Corcept Therapeutics Inc | 104.11M |
Madrigal Pharmaceuticals Inc | 21.31M |
Sarepta Therapeutics Inc | 94.52M |
FibroGen Inc | 99.48M |
Rocket Pharmaceuticals Inc | 90.78M |